Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02470793
Other study ID # 00001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2014
Est. completion date January 2021

Study information

Verified date March 2021
Source Hospital Mutua de Terrassa
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess and compare the complications and results of different lamellar endothelial keratoplasty techniques and its variations.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date January 2021
Est. primary completion date January 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Diagnosis with corneal endothelial dysfunction requiring lamellar endothelial corneal transplantation. 2. Free acceptance to be enrolled in the trial, and signature of the informed consent by the subject and/or its legal representatives. Exclusion Criteria: N/A

Study Design


Intervention

Procedure:
Descemet Stripping Automated Endothelial Keratoplasty
Descemet Stripping Automated Endothelial Keratoplasty
Descemet Membrane Endothelial Keratoplasty
Descemet Membrane Endothelial Keratoplasty

Locations

Country Name City State
Spain Hospital Universitari Mutua Terrassa Terrassa Barcelona

Sponsors (1)

Lead Sponsor Collaborator
EDUARD PEDEMONTE-SARRIAS

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual acuity First six months postoperatively
Secondary Endothelial cell density First six months postoperatively
Secondary Intraoperative complications First six months postoperatively
Secondary Postoperative complications First six months postoperatively
See also
  Status Clinical Trial Phase
Completed NCT03248037 - Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation Phase 3
Recruiting NCT03275896 - Evaluation of the Efficacy of Descemet Membrane Transplantation for the Treatment of Fuchs' Endothelial Dystrophy Early Phase 1
Completed NCT02332109 - ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy N/A
Recruiting NCT01206127 - DSAEK- Postoperative Positioning and Transplant Dislocation N/A
Recruiting NCT03407755 - Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK) N/A
Completed NCT04140422 - Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea N/A
Recruiting NCT06048380 - The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery Phase 3
Completed NCT02793310 - DMEK Versus DSAEK Study N/A
Completed NCT01795001 - The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy
Completed NCT04057053 - Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty Early Phase 1
Terminated NCT01361282 - Using the Optovue OCT to Select IOL Power N/A
Completed NCT02542644 - Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following DMEK Using Ultra-high Resolution OCT N/A
Recruiting NCT04191629 - Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema Phase 1
Completed NCT05399095 - Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty N/A
Completed NCT04752020 - Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty Early Phase 1
Not yet recruiting NCT05716945 - The OPTIMISE Study Phase 4
Recruiting NCT03575130 - Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy Phase 2
Recruiting NCT02118922 - A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Completed NCT04420429 - The Effect Of Preoperative Parameters On Success After DMEK Surgery
Withdrawn NCT04018417 - Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections. Phase 2/Phase 3